Programme
THURSDAY, 9 NOVEMBER 2023 |
||
9:00-10:30 |
Patient Advocay session (TBD) |
|
9:00-10:30 |
Sponsored Satellite Symposium (TBD) |
|
10:30-11:00 |
Coffee break |
|
11:00-12:30 |
Patient Advocay session (TBD) |
|
11:00-12:30 |
Sponsored Satellite Symposium (TBD) |
|
12:30-13:30 |
Lunch |
|
13:30-15:10
|
Opening session |
Chairs: Fatima Cardoso, PT and Larry Norton, US |
- Welcome to Lisbon | Speaker to be confirmed | |
- Welcome to ABC7 | Fatima Cardoso, PT | |
- Keynote lecture | Sarah-Jane Barker, UK | |
- ABC7 Award lecture | Speaker to be confirmed | |
15:10-15:50 |
Best Abstract Presentation |
Chairs: Eric Winer, US and Eva Schumacher-Wulf, DE |
15:50-16:20 |
Coffee break |
|
16:20-18:00
|
Clinical Dilemmas |
Chairs: V. Mueller, DE and Claire Myerson, UK |
- Impact of new early breast cancer standards in the choice of first line therapies | Eric Winer, US | |
- How to optimize care for long term responders: to be or not to be on "treatment holidays" | Joseph Gligorov, FR | |
- From DNR to ICU - expanding the rights of ABC patients | Ann H. Partridge, US | |
- New QoL tools for ABC: EU H2O project and EORTC / ABC Global Alliance tool | Galina Velikova, UK | |
- Discussion | All | |
18:00-19:30 |
Patient Advocay session (TBD) |
|
18:00-19:30 |
Sponsored Satellite Symposium (TBD) |
|
FRIDAY, 10 NOVEMBER 2023 |
||
07:30-08:30 |
Sponsored Satellite Symposium (TBD) |
|
08:30-09:10
|
Biology 1.0 |
Chairs: Mariana Chavez MacGregor, US and Alex Eniu, CH |
- Interpreting a NGS report |
Nadia Harbeck, DE |
|
- Interpreting a liquid biopsy report |
Nick Turner, UK |
|
- Interpreting a genetic test report |
Shani Paluch-Shimon, IL |
|
- Discussion |
All |
|
9:30-10:45
|
Biology 2.0 |
Chairs: Belinda Kiely, AU and Sung-Bae Kim, KR |
- Optimizing molecular subtypes classification |
William Gradishar, US |
|
- How low should we go? HER2 low, ER low |
Frédérique Penault-Llorca, FR |
|
- Redefining endocrine resistance |
Lisa Carey, US |
|
- How can Artificial Intelligence help? |
Dimitris Kalogeropoulos, UK |
|
- Discussion |
All |
|
10:45-11:15 |
Coffee break |
|
11:15-12:15
|
Loco-regional highlights |
Chairs: Elzbieta Senkus, PL and Marion Kuper, NZ |
- When should the primary tumor be treated in ABC? | Maria João Cardoso, PT | |
- Leveraging concomitant radio-targeted therapy for MBC and inoperable LABC | Birgitte Offersen, DK | |
- Revisiting oligometastatic disease | Prue Francis, AU | |
- Discussion | All | |
12:15-13:00
|
Improving Imaging of ABC |
Chairs: William J. Gradishar, US and Binghe Xu, CN |
- Optimal use of Pet-CT in ABC: new EANM-SNMMI guidelines | Lioe-Fee de Geus, NL | |
- New Imaging technologies for ABC | Frédéric Lecouvet, BE | |
- Discussion | All | |
13:00-14:00 |
Lunch and poster session |
|
14:00-15:30 |
Tough issues in ABC. Report from WebSeries | Chairs: Matti S. Aapro, CH and Gertrude Nakigudde, UG |
- ABC in a pregnant patient | Matteo Lambertini, IT | |
- Optimal management of inflammatory inoperable LABC and/or MBC | Karen Gelmon, CA | |
- Optimal management of a patient with ABC in visceral crisis | Hope Rugo, US | |
- Management a patient with ABC and HIV | Peter Vuylsteke, BW | |
- Optimal management of an older frail patient with ABC | Laura Biganzoli, IT | |
- Management of leptomeningeal disease |
Sandra Swain, US |
|
15:30-15:50 |
Coffee break |
|
15:50-17:05
|
The perfect storm: war, recession, regulatory/payers hurdles |
Chairs: Nagi S. El Saghir, LB, Carlos H. Barrios, BR and Bertha Aguilar, MX |
- Caring for cancer patients amidst war |
Richard Sullivan, UK |
|
- Barriers and inequalities due to old fashion regulatory and / or recruitment rules |
Bishal Gyawali, CA |
|
- Will the WHO Global Breast Cancer Initiative (GBCI) help ABC patients? |
Andre Ilbawi, CH |
|
- The new Lancet Commission on BC: a powerful lobbying for ABC |
Charlotte Coles, UK |
|
- Discussion |
All |
|
17:05-18:00
|
News from ABC6 |
Chairs: Silvia Neciosup, PE and Shinji Ohno, JP |
- HER2+ |
Javier Cortes, ES |
|
- ER+ / Her2 Neg |
Sandra Franco, CO |
|
- Triple negative |
Rebecca Dent, SG |
|
- Discussion |
All |
|
18:00-19:30 |
Patient Advocay session (TBD) |
|
18:00-19:30 |
Sponsored Satellite Symposium (TBD) |
|
SATURDAY, 11 NOVEMBER 2023 |
||
8:30-10:30 |
Consensus session (part I) |
ABC7 Chairs, Scientific Committee Members and Panellists |
10:30-11:00 |
Coffee break |
|
11:00-11:15 |
Report from ABC Patient Advocacy Committee |
Speaker to be confirmed |
11:15-12:45 |
Consensus session (part II) |
ABC7 Chairs, Scientific Committee Members and Panellists |
12:45-13:00 |
Close |
|